Paysign, Inc. ( NASDAQ:PAYS ) last week reported its latest first-quarter results, which makes it a good time for...
Robust Growth in Pharma Patient Affordability and Plasma Services Drive Financial Results
First quarter 2024 total revenues of $13.2 million, up 30% from first quarter 2023 First quarter 2024 net income of $309 thousand, or diluted earnings per share of $0.01, versus net loss of $160 thousand, or diluted earnings per share of $(0.00) for ...